Tipping Comp - what will RAP’s Revenue be sales in Sept. Qtr, page-52

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 52 Last

Share
Profile

Follow
Tech goose

2,707 Posts.

504

28/09/20

14:35

Post #: 47679833
Share

Originally posted by rajboon ↑

I say In my opinion, TK must leave and the company should get a better CEO who can sell the product.
We are in the middle of the worst respiratory-related pandemic of the century.
ResApp has a respiratory disease diagnostic product which can be utilized during this pandemic
Still, our CEO cant sell
TK list of negative achievements or failures:
1. Failed 1st US trial, maybe because of his careless or stubborn attitude?
2. Doctors without border exiting the project
3. Less than optimal results in 2nd US trial
4. Sanofi exiting
5. FDA rejection
6. Millions of dollars in capital raise
7. He got millions of shares for 1c and 2c and 5c?
8. His annual salary >280k

I am sure he has some success as well like successful Australian clinical trial, TGA, CE approval, COVIU, Phenix deals, etc. but if we look back and assess his failures will definitely outweigh his success.
My problems with him are:
His stubbornness
not learning from his mistakes
not be sorry and own responsibilities
his lies about capital raise and company position

This may be my first post on resapp, but I have been following this company since the start & know its history. I know mostly all posters (downramper, upramper, genuine...) on this forum and I respect their knowledge.

Expand

I just forwarded your post to TK to light a fire under his butt

Last edited by Tech goose: 28/09/20

RAP Price at posting: 10.5¢ Sentiment: Hold Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

CC9

Chariot locks in high-potential drill target at Black Mountain, one of the USA's largest lithium landholdings

FL1

First Lithium hits high-grade mineralisation in all holes of diamond program in Mali

STK

Strickland Metals jumps on mammoth gold-copper-silver hit over 300m width at Serbian Rogozna Project

The Rising Tide: How institutional adoption is shaping the future of crypto

CU6

US FDA awards Clarity Pharma's novel prostate cancer PET scan imaging compound fast track status

There are more pages in this discussion • 68 more messages in this thread...

First 52 Last

Add RAP (ASX) to my watchlist

Tipping Comp - what will RAP’s Revenue be sales in Sept. Qtr, page-52

Top Stories

Chariot locks in high-potential drill target at Black Mountain, one of the USA's largest lithium landholdings

First Lithium hits high-grade mineralisation in all holes of diamond program in Mali

Strickland Metals jumps on mammoth gold-copper-silver hit over 300m width at Serbian Rogozna Project

The Rising Tide: How institutional adoption is shaping the future of crypto

US FDA awards Clarity Pharma's novel prostate cancer PET scan imaging compound fast track status

Featured News